Healthcare shares have weakened, bringing CSL, Mesoblast and Pro Medicus into focus as innovation and long-term demand continue supporting the sector.
Could the Healthcare Dip Put CSL (ASX:CSL) Back in Focus?
Healthcare shares have weakened, bringing CSL, Mesoblast and Pro Medicus into focus as innovation and long-term demand continue supporting the sector.